Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?

European Journal of Surgical Oncology

Volumn 41, Issue 9, 2015, Pages 1162-1169

  Ercolani, G ^a   Dazzi, A ^a   Giovinazzo, F ^b   Ruzzenente, A ^b   Bassi, C ^b   Guglielmi, A ^b   Scarpa, A ^b   D'Errico, A ^a   Pinna, A D ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Cholangiocarcinoma; Hepatectomy; Outcome; Prognosis; Risk factors

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER CLASSIFICATION; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PERINEURAL INVASION; PRIORITY JOURNAL; PROBABILITY; TUMOR INVASION; WEDGE RESECTION; AGED; BILE DUCT; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLASSIFICATION; DISEASE FREE SURVIVAL; HEPATIC DUCT; INTRAHEPATIC BILE DUCT; LYMPH NODE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84938748958     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.05.013     Document Type: Article

References (55)

1. A. Nakeeb, H.A. Pitt, T.A. Sohn, and et al. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 4 1996 Oct 463 473
2. S.A. Khan, S. Emadossadaty, N.G. Ladep, and et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 56 2012 848 854
3. T. Von Hahn, S. Ciesek, G. Wegener, and et al. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany Scand J Gastroenterol 46 9 2011 Sep 1092 1098
4. C. Luke, T. Price, and D. Roder Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population Asian Pac J Cancer Prev 11 6 2010 1479 1485
5. T. Patel Worldwide trends in mortality from biliary tract malignancies BMC Cancer 2 2002 10
6. A. Guglielmi, A. Ruzzenente, A. Valdegamberi, and et al. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients Eur J Surg Oncol 40 2014 567 575
7. G.L. Tyson, and H.B. El-Serag Risk factors for cholangiocarcinoma Hepatology 54 1 2011 Jul 173 184
8. E. Sinakos, A.K. Saenger, J. Keach, W.R. Kim, and K.D. Lindor Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma Clin Gastroenterol Hepatol 9 5 2011 May 434 439
9. S. Singh, S.J. Tang, J. Sreenarasimhaiah, L.F. Lara, and A. Siddiqui The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma Dig Dis Sci 56 8 2011 Aug 2491 2496
10. N.J. Smits, and J.W. Reeders Imaging and staging of biliopancreatic malignancy: role of ultrasound Ann Oncol 10 Suppl. 4 1999 20 24
11. A. Weber, R.M. Schmid, and C. Prinz Diagnostic approaches for cholangiocarcinoma World J Gastroenterol 14 26 2008 Jul 14 4131 4136
12. R. Sasaki, T. Kondo, T. Oda, and et al. Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma Am J Surg 202 4 2011 Oct 441 448
13. K.J. Fowler, J.J. Brown, and V.R. Narra Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis Hepatology 54 6 2011 Dec 2227 2237
14. K. Alkhawaldeh, S. Faltten, H.J. Biersack, and S. Ezziddin The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis Clin Nucl Med 36 10 2011 Oct 879 883
15. A. Sacks, P.J. Peller, D.S. Surasi, L. Chatburn, G. Mercier, and R.M. Subramaniam Value of PET/CT in the management of primary hepatobiliary tumors, part 2 AJR Am J Roentgenol 197 2 2011 Aug W260 W265
16. X.F. Liu, X.T. Zhou, and S.Q. Zou An analysis of 680 cases of cholangiocarcinoma from 8 hospitals Hepatobiliary Pancreat Dis Int 4 4 2005 Nov 585 588
17. M.A. Silva, K. Tekin, F. Aytekin, S.R. Bramhall, J.A. Buckels, and D.F. Mirza Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK Eur J Surg Oncol 31 5 2005 Jun 533 539
18. N. Coelho-Prabhu, and T.H. Baron Endoscopic retrograde cholangiopancreatography in the diagnosis and management of cholangiocarcinoma Clin Liver Dis 14 2 2010 333 348
19. J. Hochberger, and G. D'Addazio Endoscopic tumor treatment in the bile duct Gastrointest Endosc Clin N Am 19 4 2009 Oct 597 600
20. C. Gerges, B. Schumacher, G. Terheggen, and H. Neuhaus Expandable metal stents for malignant hilar biliary obstruction Gastrointest Endosc Clin N Am 21 3 2011 Jul 481 497
21. A. Parodi, D. Fisher, M. Giovannini, T. Baron, and M. Conio Endoscopic management of hilar cholangiocarcinoma Nat Rev Gastroenterol Hepatol 9 2 2012 Jan 24 105 112
22. M. Sut, R. Kennedy, J. McNamee, A. Collins, and B. Clements Long-term results of percutaneous transhepatic cholangiographic drainage for palliation of malignant biliary obstruction J Palliat Med 13 11 2010 Nov 1311 1313
23. Y. Nimura, N. Hayakawa, J. Kamiya, S. Kondo, and S. Shionoya Hepatic segmentectomy with lobe caudate resection for bile duct carcinoma of the hepatic hilus World J Surg 14 1990 535 544
24. R.K. Tompkins, K. Saunders, J.J. Roslyn, and W.P. Longmire Changing patterns in diagnosis and management of bile duct cancer Ann Surg 211 5 1990 May 614 621
25. D.R. Farley, A.L. Weaver, and D.M. Nagorney "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention Mayo Clin Proc 70 5 1995 May 425 429
26. R. Reding, J.L. Buard, G. Lebeau, and B. Launois Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French surgical association survey Ann Surg 213 3 1991 Mar 236 241
27. F.F. Chou, S.M. Sheen-Chen, C.L. Chen, Y.S. Chen, and M.C. Chen Prognostic factors of resectable intrahepatic cholangiocarcinoma J Surg Oncol 59 1 1995 May 40 44
28. J.L. Cameron, H.A. Pitt, M.J. Zinner, S.L. Kaufman, and J. Coleman Management of proximal cholangiocarcinomas by surgical resection and radiotherapy Am J Surg 159 1 1990 Jan 91 98
29. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. (Eds.).7th ed. 2010.
30. P.A. Clavien, J. Barkun, M. De Oliveira, and et al. The Clavien-Dindo classification of surgical complications five-year experience Ann Surg 250 2009 187 196
31. M. DeOliveira, S. Cunningham, J. Cameron, and et al. Cholangiocarcinoma: thirty-one experience with 564 patients at a single Institution Ann Surg 245 2007 755 762
32. J.Y. Madariaga, S. Iwatsuki, S. Todo, and et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases Ann Surg 227 1998 70 79
33. S.T. Kelle, S.T. Kelley, M. Blooston, and et al. Cholangiocarcinoma: advocate an aggressive approach with adjuvant chemotherapy Am Surg 70 2004 743 748
34. Y. Murakami, K. Uemura, T. Sudo, and et al. Prognostic factors after surgical resection for intrahepatic, hilar and siatl cholangiocarcinoma Ann Surg Oncol 18 2011 651 658
35. G. Ercolani, M. Zanello, G.L. Grazi, and et al. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a western single center J Hepatobiliary Pancreat Sci 17 3 2010 May 329 337
36. A. Guglielmi, A. Ruzzenente, A. Campagnaro, and et al. Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol 101 2010 111 115
37. T. Ebata, H. Watanabe, Y. Ajioka, K. Oda, and Y. Nimura Pathological appraisal of lines of resection for bile duct carcinoma Br J Surg 89 10 2002 Oct 1260 1267
38. Y. Nimura, N. Hayakawa, J. Kamiya, and et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract Hepatogastroenterology 38 2 1991 Apr 170 175
39. K. Tsukada, K. Yoshida, T. Aono, and et al. Major hepatectomy and pancreatoduodenectomy for advanced carcinoma of the biliary tract Br J Surg 81 1 1994 Jan 108 110
40. S. Hirono, M. Tani, M. Kawai, S. Ina, K. Uchiyama, and H. Yamaue Indication of hepatopancreatoduodenectomy for biliary tract cancer World J Surg 30 4 2006 Apr 567 573
41. M. D'Angelica, R.C. Martin 2nd, W.R. Jarnagin, Y. Fong, R.P. DeMatteo, and L.H. Blumgart Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer J Am Coll Surg 198 4 2004 Apr 570 576
42. T. Ebata, M. Nagino, H. Nishio, T. Arai, and Y. Nimura Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability J Hepatobiliary Pancreat Surg 14 2 2007 131 135
43. Y. Kaneoka, A. Yamaguchi, M. Isogai, and T. Kumada Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy World J Surg 34 11 2010 Nov 2662 2670
44. S.D. Murad, W. Ray Kim, T. Therneau, and et al. Predictors of pre-transplant dropout and post-transplant recurrence in patients with perihilar cholangiocarcinoma Hepatology 56 2012 972 981
45. M. Nagino, T. Ebata, Y. Yokoyama, and et al. Evolution of surgical treatment for perihilar cholangiocarcinoma Ann Surg 258 2013 129 140
46. K. Matsuo, F. Rocha, K. Ito, and et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of respectability and outcomes in 380 patients J Am Coll Surg 215 2012 343 355
47. D. Tamandl, K. Kaczirek, B. Gruenberger, and et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma Br J Surg 96 2009 919 925
48. G. Ercolani, G.L. Grazi, M. Ravaioli, and et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy Ann Surg 239 2 2004 Feb 202 209
49. G. Ercolani, G. Vetrone, G.L. Grazi, and et al. Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival Ann Surg 252 1 2010 Jul 107 114
50. I. Gockel, M. Domeyer, T. Wolloscheck, and et al. Resection of the mesopancreas: a new surgical classification of a known anatomical space W J Surg Oncol 5 2007 44
51. J. Gaedcke, B. Gunawan, M. Grade, and et al. The mesopancreas is the primary site of R1 resection in pancreatic head cancer: relevance for clinical trials Langen Arch Surg 395 2010 451 458
52. I. Esposito, J. Kleef, F. Bergmann, and et al. Most pancreatic cancer resections ar R1 resection Ann Surg Oncol 15 2008 1651 1660
53. C.S. Verbeke, D. Leitch, K.V. Menon, and et al. Redifining the R1 resection in pancreatic cancer Br J Surg 93 2006 1232 1237
54. M. Simbolo, M. Fassan, A. Ruzzenente, and et al. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups Oncotarget 5 9 2014 2839 2852
55. Y. Jiao, T.M. Pawlik, R.A. Anders, and et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinoma Nat Genet 45 2013 1470 1473